Groundhog Day for Amarin (AMRN); MKM Not Positive on NCE Status Although Company Remains Upbeat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. AMAT
2. SPY
3. GLOB
4. RDDT
5. GNK
6. HTFL
7. SNDK
8. WDAY
9. ADYEN:NA
10. DVLT

Go back to Groundhog Day for Amarin (AMRN); MKM Not Positive on NCE Status Although Company Remains Upbeat

Volatility to Continue for Amarin (AMRN) with No NCE Decision, But Serious Upside Exists - Jefferies

November 19, 2012 8:20 AM EST

Jefferies commented on Amarin Corporation (NASDAQ: AMRN) after this month's FDA Orange Book update contained no decision on 5-year versus 3-year exclusivity for Vascepa.

While the firm expects more volatility with no NCE decision, Amarin's 10-Q, stating - "We have been informed by FDA that the FDA has drafted a proposed response letter to our exclusivity request, that such draft response letter has been circulated internally at the FDA for comment and the FDA has been considering the issue actively" - is a modest positive.

"There may be... More

Amarin Corp (NASDAQ: AMRN) NCE status isn't update in FDA Orange Book for October

November 16, 2012 2:18 PM EST

Amarin Corp (NASDAQ: AMRN) NCE status isn't update in FDA Orange Book for October.... More

Amarin (AMRN) Sees Downside Action

November 16, 2012 1:22 PM EST

Amarin Corporation plc (NASDAQ: AMRN) sees downside. NCE decision expected soon.... More

Amarin (AMRN) Higher as Teva (TEVA) Said to be Waiting in the Wings for a Takeover

November 15, 2012 7:40 AM EST

Amarin Corp Plc (NASDAQ: AMRN) is surging higher in pre-open trading Thursday following reports from Calcalist that Teva Pharmaceutical (NASDAQ: TEVA) is the leading candidate to acquire the company. AstraZeneca (NYSE:... More